Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)
JavaScript is disabled for your browser. Some features of this site may not work without it.
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)
Matzinger, Oscar; Heimsoth, Irma; Gulyban, Akos; Pierart, Marianne; Van Tienhoven, Geertjan; Poortmans, Philip; Collette, Laurence; Struikmans, Henk; Van Den Bogaert, Walter; Bartelink, Harry; Fourquet, Alain; Ataman, Fatma
Introduction. The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first results are expected in 2012. We present the toxicity reported until year 3 after treatment.